Vext Science Inc (FRA:VV5)
€ 0.087 -0.049 (-36.03%) Market Cap: 38.30 Mil Enterprise Value: 63.26 Mil PE Ratio: 0 PB Ratio: 0.76 GF Score: 62/100

Q1 2025 Vext Science Inc Earnings Call Transcript

May 21, 2025 / 12:00PM GMT
Release Date Price: €0.06 (-4.00%)

Key Points

Positve
  • Vext Science Inc (VEXTF) reported a significant revenue increase to $11.6 million in Q1 2025, driven by strong performance in the Ohio market.
  • The company achieved a robust operating cash flow of $3.1 million, nearly matching its entire operating cash flow for 2024.
  • Vext's cash flow margin exceeded 26%, placing it among the top cash flow producers across US public multi-state cannabis operators.
  • The company's retail-first strategy is yielding strong unit economics, with consolidated retail sales in Ohio growing by 7% in Q1 2025.
  • Vext completed the acquisition of two dispensaries from Big Perm, doubling its Ohio retail footprint to four locations, with plans to expand further.
Negative
  • The Arizona market remains pressured, with total sales down 13% year-over-year, impacting Vext's performance in the state.
  • Pricing compression in the Ohio adult-use market is creating challenges, requiring operators to remain disciplined on margins.
  • Vext's gross margins have been volatile, with lower margins reported in Q1 2025 compared to previous quarters.
  • The company faces uncertainties regarding the final adult-use rules in Ohio, which could impact future operations.
  • Vext is experiencing pricing pressures in the wholesale market, which could affect profitability if not managed carefully.
Operator

Thank you for standing by. This is the conference operator. Welcome to the Vext Science first-quarter 2025 financial results conference call. (Operator Instructions) The conference is being recorded. (Operator Instructions)

I would now like to turn the conference over to [Priam Chakraborty]. Please go ahead.

Priam Chakraborty
Vext Science Inc

Thanks, operator. Good morning, everyone, and thank you for joining us today. Vext's first-quarter 2025 financial results were released earlier this morning. The press release, financial statements, and MD&A are available on SEDAR+ as well as on the Vext website at vextscience.com.

We would like to remind listeners that portions of today's discussion include forward-looking statements and that forward-looking statements are included in today's filing. There can be no assurance that these forward-looking statements will prove to be accurate or that management's expectations or estimates of future developments, circumstances, or results contained therein will materialize.

Risks and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot